158 related articles for article (PubMed ID: 38891789)
1. The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies.
Dithmer S; Blasig IE; Fraser PA; Qin Z; Haseloff RF
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891789
[TBL] [Abstract][Full Text] [Related]
2. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.
Liu WY; Wang ZB; Zhang LC; Wei X; Li L
CNS Neurosci Ther; 2012 Aug; 18(8):609-15. PubMed ID: 22686334
[TBL] [Abstract][Full Text] [Related]
3. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
Greene C; Campbell M
Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
[TBL] [Abstract][Full Text] [Related]
4. Determination of Tight Junction Integrity in Brain Endothelial Cells Based on Tight Junction Protein Expression.
Alluri H; Peddaboina CS; Tharakan B
Methods Mol Biol; 2024; 2711():235-240. PubMed ID: 37776462
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
[TBL] [Abstract][Full Text] [Related]
6. miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.
Harati R; Hammad S; Tlili A; Mahfood M; Mabondzo A; Hamoudi R
PLoS One; 2022; 17(1):e0262152. PubMed ID: 35025943
[TBL] [Abstract][Full Text] [Related]
7. Methods used for the measurement of blood-brain barrier integrity.
Sun H; Hu H; Liu C; Sun N; Duan C
Metab Brain Dis; 2021 Jun; 36(5):723-735. PubMed ID: 33635479
[TBL] [Abstract][Full Text] [Related]
8. Tight junctions in neurological diseases.
Bednarczyk J; Lukasiuk K
Acta Neurobiol Exp (Wars); 2011; 71(4):393-408. PubMed ID: 22237490
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Analysis of Tight Junction Proteins.
Greene C; Campbell M
Methods Mol Biol; 2022; 2492():307-314. PubMed ID: 35733053
[TBL] [Abstract][Full Text] [Related]
10. Differences in the molecular structure of the blood-brain barrier in the cerebral cortex and white matter: an in silico, in vitro, and ex vivo study.
Nyúl-Tóth Á; Suciu M; Molnár J; Fazakas C; Haskó J; Herman H; Farkas AE; Kaszaki J; Hermenean A; Wilhelm I; Krizbai IA
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1702-14. PubMed ID: 27059078
[TBL] [Abstract][Full Text] [Related]
11. Damage to the Blood Brain Barrier Structure and Function from Nano Titanium Dioxide Exposure Involves the Destruction of Key Tight Junction Proteins in the Mouse Brain.
Hong F; Mu X; Ze Y; Li W; Zhou Y; Ji J
J Biomed Nanotechnol; 2021 Jun; 17(6):1068-1078. PubMed ID: 34167621
[TBL] [Abstract][Full Text] [Related]
12. Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders.
Lochhead JJ; Yang J; Ronaldson PT; Davis TP
Front Physiol; 2020; 11():914. PubMed ID: 32848858
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.
Abdullahi W; Tripathi D; Ronaldson PT
Am J Physiol Cell Physiol; 2018 Sep; 315(3):C343-C356. PubMed ID: 29949404
[TBL] [Abstract][Full Text] [Related]
14. Tight junction proteins related to blood-brain barrier and their regulatory signaling pathways in ischemic stroke.
Zheng X; Ren B; Gao Y
Biomed Pharmacother; 2023 Sep; 165():115272. PubMed ID: 37544283
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells.
Burek M; König A; Lang M; Fiedler J; Oerter S; Roewer N; Bohnert M; Thal SC; Blecharz-Lang KG; Woitzik J; Thum T; Förster CY
Transl Stroke Res; 2019 Dec; 10(6):672-683. PubMed ID: 30617994
[TBL] [Abstract][Full Text] [Related]
16. Occludin: a gatekeeper of brain Infection by HIV-1.
Torices S; Daire L; Simon S; Naranjo O; Mendoza L; Teglas T; Fattakhov N; Adesse D; Toborek M
Fluids Barriers CNS; 2023 Oct; 20(1):73. PubMed ID: 37840143
[TBL] [Abstract][Full Text] [Related]
17. Barrier function in the peripheral and central nervous system-a review.
Reinhold AK; Rittner HL
Pflugers Arch; 2017 Jan; 469(1):123-134. PubMed ID: 27957611
[TBL] [Abstract][Full Text] [Related]
18. Matrix stiffness regulates the tight junction phenotypes and local barrier properties in tricellular regions in an iPSC-derived BBB model.
Yan L; Dwiggins CW; Moriarty RA; Jung JW; Gupta U; Brandon KD; Stroka KM
Acta Biomater; 2023 Sep; 167():109-120. PubMed ID: 37302732
[TBL] [Abstract][Full Text] [Related]
19. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
Feng S; Zou L; Wang H; He R; Liu K; Zhu H
Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623
[TBL] [Abstract][Full Text] [Related]
20. Expression of VEGF- and tight junction-related proteins in the neocortical microvasculature of patients with drug-resistant temporal lobe epilepsy.
Castañeda-Cabral JL; Colunga-Durán A; Ureña-Guerrero ME; Beas-Zárate C; Nuñez-Lumbreras MLA; Orozco-Suárez S; Alonso-Vanegas M; Guevara-Guzmán R; Deli MA; Valle-Dorado MG; Sánchez-Valle V; Rocha L
Microvasc Res; 2020 Nov; 132():104059. PubMed ID: 32798551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]